Business Acquisitions - Total purchase price (Details) - USD ($) |
Sep. 30, 2021 |
Sep. 03, 2021 |
Jul. 01, 2021 |
Dec. 31, 2020 |
Oct. 30, 2020 |
Dec. 31, 2019 |
---|---|---|---|---|---|---|
Business Acquisition [Line Items] | ||||||
Goodwill | $ 5,885,628 | $ 871,128 | $ 741,128 | |||
Michael F. Hamant, M.D., P.C | ||||||
Business Acquisition [Line Items] | ||||||
Goodwill | $ 130,000 | |||||
PP&E | 10,000 | |||||
Total Purchase Price | $ 140,000 | |||||
Neisa I. Diaz, M.D., LLC | ||||||
Business Acquisition [Line Items] | ||||||
Aquired Intangibles | $ 1,840,000 | |||||
Other Assets | 2,037 | |||||
Goodwill | 1,960,000 | |||||
Total Purchase Price | $ 3,802,037 | |||||
Medical Associates of Tampa Bay, LLC | ||||||
Business Acquisition [Line Items] | ||||||
Aquired Intangibles | $ 240,000 | |||||
Goodwill | $ 3,805,628 | 892,550 | $ 871,128 | |||
PP&E | 21,450 | |||||
Total Purchase Price | $ 1,154,000 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of intangible assets, excluding goodwill, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of property, plant, and equipment recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|